News ()

  2014

September   Lucane Pharma exhibits at the ICIEM in Innsbruck.

August   Pheburane is granted Orphan Drug Designation in Australia.

July   Lucane Pharma and Accesia sign an exclusive distribution agreement concerning GranuPAS for Greece and Balkan countries.

April   Lucane Pharma and Orpharma sign an exclusive distribution agreement concerning Pheburane for Australia and New Zealand.
First pre-NDA meeting with FDA concerning Pheburane for the USA.
Lucane Pharma is granted the EU Marketing Authorization for GranuPAS with an Orphan Drug status.
Kolbam gets the EU Marketing Authorization with an Orphan Drug status.
Lucane Pharma and Medical Need sign an exclusive distribution agreement concerning GranuPAS for the Baltics and some CEE countries.
Lucane Pharma and Metabolica sign an exclusive distribution agreement concerning Pheburane for Colombia.

March   Lucane receives positive opinion for Paser (approved trademark: GranuPAS) by the CHMP.
Lucane Pharma and TrueMed sign an exclusive distribution agreement concerning Pheburane for Israel.

February   Lucane Pharma gets continued financial support from OSEO based on the progress of the research program LUC 03.

January   Lucane Pharma and Accesia sign an exclusive distribution agreement concerning Pheburane for Greece and Balkan countries.

  2013

  2012

  2011

© Lucane Pharma    |    Legal information ()